Alcoholic hepatitis, also known as alcohol-induced hepatitis, is liver inflammation caused by drinking large amounts of alcohol over many years. It is a more advanced stage of alcohol-associated fatty liver disease (AFLD), in which the high consumption of alcohol causes a buildup of fat in the liver, leading to liver inflammation (hepatitis).
The symptoms of alcoholic hepatitis are similar to other forms of hepatitis, including fatigue, nausea, upper-right abdominal pain, and jaundice (yellowing of the skin and eyes). Stopping alcohol can potentially reverse liver injury before it leads to cirrhosis, the most advanced stage of AFLD.
This article explains how alcoholic hepatitis develops and ways to recognize it when it occurs. It also describes how alcoholic hepatitis is treated, including its impact on life expectancy.
Alcohol Consumption and Alcoholic Hepatitis
The criteria for alcoholic hepatitis, as defined by the National Institute of Alcoholism and Alcohol Abuse, is the rapid onset of jaundice after the high consumption of alcohol for at least six months. High consumption translates to over 40 grams (g) of alcohol per day in females and over 50 g of alcohol per day in males (with one standard drink equaling 14 g).
With that said, alcoholic hepatitis is not dose-dependent. Although alcoholic hepatitis can occur within a relatively short period (particularly in those who binge drink), it is more often seen in people with a long history of heavy alcohol use, typically those who consume eight to 10 drinks per day for 10 years or more.
A Note on Gender and Sex Terminology
Verywell Health acknowledges thatsex and genderare related concepts, but they are not the same. To accurately reflect our sources, this article uses terms like “female,” “male,” “woman,” and “man” as the sources use them.
From Fatty Liver Disease to Alcoholic Hepatitis
Alcoholic hepatitis is a manifestation of alcohol-associated fatty liver disease, also known as alcoholic liver disease. With AFLD, the overconsumption of alcohol causes the accumulation of fat in the liver, known as hepatosteatosis.
While hepatosteatosis is largely asymptomatic (without symptoms), the underlying inflammation can build as the fatty deposits increase, eventually leading to symptoms of hepatitis.
Hepatitis disrupts the normal function of the liver. Among other things, it speeds up the normal breakdown of red blood cells in the liver. This breakdown leads to the excessive release of a yellowish waste product called bilirubin, which causes jaundice.
Between 10% and 20% of people with alcoholic hepatitis will progress to cirrhosis. This is a more advanced stage of AFLD characterized by the accumulation of scar tissue in the liver and the progressive loss of liver function.
Other Risk Factors
Alcoholic hepatitis affects 30% to 40% of people with excessive alcohol consumption. While the amount and duration of drinking influence the risk, other factors can contribute, including:
- Older age: With symptoms typically starting between the ages of 40 and 50
- Being female: Due in part to smaller body size and slower metabolism of alcohol
- Obesity: Which speeds the development of hepatosteatosis
- A history of binge drinking: Especially in younger adults with AFLD
- Malnutrition: Common in people with alcohol use disorder due to impaired nutrient absorption
- Genetics: Including inherited mutations that impair the production of enzymes that metabolize alcohol
Understanding Fatty Liver Disease
How Do Alcoholic Hepatitis Symptoms Begin?
Alcoholic hepatitis is characterized by the rapid onset of hepatitis symptoms, otherwise known as acute hepatitis. The symptoms may start mildly and become progressively worse if drinking continues.
Signs and symptoms of alcoholic hepatitis include:
- Fatigue
- Fever
- Itchiness
- Generalized weakness
- Loss of appetite
- Upper-right abdominal swelling, tenderness, or pain
- Nausea or vomiting
- Jaundice
In severe cases, alcoholic hepatitis can lead to the buildup of fluid in the abdomen, called ascites, and neurological symptoms such as confusion, reduced alertness, and personality changes due to hepatic encephalopathy. Both are signs of severe liver dysfunction.
Importance of Early Diagnosis
Recognizing the signs of alcoholic hepatitis is the first step to preventing the progression of liver disease. An extensive evaluation is needed to differentiate AFLD from conditions with similar symptoms, like hepatitis B, hepatitis C, autoimmune hepatitis, or metabolic dysfunction-associated steatohepatitis (MASH).
Medical Review and Physical Exam
The diagnosis of alcoholic hepatitis starts with a review of your medical history and a physical exam.
During the physical exam, the healthcare provider will look for other signs, such as spider angioma (spider veins), palmar erythema (palm redness), tachycardia (rapid heartbeat), tremors, and peripheral edema (swelling of the ankles and feet). All of these are common in people with alcohol use disorder (alcoholism).
The provider will also ask questions to determine if alcohol is the likely cause, including:
- How often do you drink alcohol?
- How many drinks do you consume in one sitting?
- How often do you drink six or more drinks in one sitting?
Lab Tests and Procedures
Based on the initial findings, your healthcare provider will order tests to help firmly establish AFLD as the cause of your symptoms.
These typically include:
- Urinalysis: A urine test can detect compounds like ethyl sulfate and ethyl glucuronide that are increased when alcohol is heavily consumed.
- Complete blood count (CBC): This panel of blood tests can detect abnormalities commonly seen with heavy alcohol use, including high neutrophils (a type of white blood cell) and low platelets (a blood cell active in clotting).
- Serum phosphatidylethanol: This blood test can detect phosphatidylethanol, a compound that occurs only in the presence of alcohol.
- Liver function tests (LFTs): This panel of blood tests can help establish if alcohol is the cause based on the ratio of enzymes aspartate aminotransferase(AST) andalanine aminotransferase(ALT).
Other procedures may be ordered to characterize the severity of AFLD and determine if cirrhosis is present:
- Fibroscan: This noninvasive form of abdominal ultrasound is designed specifically to detect and measure liver fibrosis (scarring).
- Liver biopsy: This is the extraction of a sample of liver tissue, usually with a hollow core needle, to diagnose hepatosteatosis, cirrhosis, and other liver diseases, like liver cancer.
MELD Scoring
The treatment of alcoholic hepatitis is directed by classification systems that score the severity of liver disease. The system most commonly used is the Model for End-Stage Liver Disease (MELD) score, which classifies liver disease based on the results of liver function tests.
MELD scores range from 6 for mild liver dysfunction to 40 for severe liver disease. MELD scores can also predict the likely outcome (prognosis) of treatment.
What Are Signs of Liver Disease?
Reversing Alcoholic Hepatitis
Mild alcoholic hepatitis doesn't usually cause any damage and can be reversed by stopping alcohol use. For those who quit, liver enzymes will usually return to normal within a few months. Continued cessation can also reverse AFLD.
Continued heavy drinking can increase the risk of cirrhosis, which largely is irreversible.
Cirrhosis is caused by the dysfunction of hepatic stellate cells (HSCs), which secrete collagen to maintain the liver's structural integrity. When exposed to persistent inflammation, HSCs overproduce collagen, causing a tangle of cells that progressively scar and damage the liver.
Cirrhosis is considered compensated when the liver is still functional. When the damage is so extensive as to cause liver failure, you are said to have decompensated cirrhosis. With end-stage liver disease, a liver transplant is the only means of survival.
Common Complications of Cirrhosis
Effect on Life Expectancy
Though alcoholic hepatitis is largely reversible once drinking is stopped, it is not always so. In some people, the damage can be permanent and even deadly.
In cases of severe alcoholic hepatitis, an extreme drop in platelets can lead to bleeding in the gastrointestinal tract known as variceal hemorrhage. Along with ascites and hepatic encephalopathy, variceal bleeding is associated with an increased risk of death.
Studies suggest that severe alcoholic hepatitis is associated with a 180-day mortality (death) rate of 40%. Moreover, it increases the risk of cirrhosis ninefold compared to people with mild hepatitis.
While it may be reasonable to assume that the risk increases with the amount of alcohol you drink, factors like genetics, sex, and weight can predispose you to severe hepatitis at far lower levels.
Smoking can also contribute by increasing the risk of portal hypertension (high blood pressure in the portal vein of the liver). This increases the risk of variceal bleeding and irreversible liver damage.
What Is the Life Expectancy With Cirrhosis?
Cirrhosis is linked to reduced life expectancy. Research suggests that the five-year survival rate in the United States is 73%—meaning that 73 out of 100 people will live for at least five years. By 10 years, the survival rate drops to 54%.
Predicting Survival
Life expectancy can also be estimated based on MELD scores. The MELD score is typically used to prioritize who gets a liver transplant but can also be useful in determining survival in people with alcoholic hepatitis.
The MELD score predicts life expectancy based on the observed mortality (meaning the percentage of people who will die within a specific time frame). The 90-day observed mortality for alcoholic hepatitis is currently described as follows:
MELD score | 90-day observed mortality (%) |
---|---|
9 or less | 1.9% |
10–19 | 6.0% |
20–29 | 19.6% |
30–39 | 52.6% |
40 and over | 71.3% |
Life Expectancy With Cirrhosis
Alcoholic Hepatitis Treatment
The treatment of alcoholic hepatitis is based on the severity of liver disease as classified by the MELD score.
With AFLD, the treatment may involve:
- Alcohol cessation: Quitting drinking is the number one priority, regardless of MELD score. Recovery should be directed by an addiction specialist to avoid potentially severe withdrawal symptoms caused by quitting cold turkey.
- Nutritional support: Malnutrition is a common feature of alcohol use disorder. Increased calories and protein may help reduce the risk or severity of hepatic encephalopathy.
- Corticosteroids: Oral corticosteroids (steroids) like prednisolone are generally prescribed for MELD scores of 25 or greater. These drugs quickly lower liver inflammation.
- Pentoxifylline: This oral drug may be taken with prednisolone for people with variceal bleeding or a severe complication called hepatorenal syndrome involving the kidneys.
- N-acetylcysteine: This drug is given intravenously (into a vein) to decrease the risk of hepatorenal syndrome.
- Liver transplantation: While a liver transplant is the standard of care for decompensated cirrhosis, experts are increasingly calling for the early use of liver transplants to increase life expectancy in people with severe alcoholic hepatitis.
How Liver Disease Is Treated
How to Adapt to Lifestyle Changes Without Alcohol
Quitting alcohol is rarely easy if you have been drinking heavily for years. Alcohol recovery programs are essential for those who can't quit, including faith-based 12-step programs like Alcoholics Anonymous (AA) or science-based programs like SMART Recovery.
Whatever program you choose, these eight tips can help you better adapt to an alcohol-free lifestyle:
- Put your goals in writing: This includes the benefits of cessation to your liver and your relationships, work, and general well-being.
- Don't keep alcohol in the house: If you want to have friends over, have them bring their own drinks and take them home afterward.
- Watch for peer pressure: Practice politely saying no. If people can't respect your wishes, avoid them in situations where there is alcohol.
- Socialize in alcohol-free zones: This includes coffeehouses and movie theaters, where drinking is not central to the social experience. Drinking is also less of a social requisite at lunch.
- Find nonalcoholic alternatives: An ever-increasing range of nonalcoholic beers, wines, and spirits are available online and in stores. These can help you socialize without alcohol.
- Find hobbies: Hobbies help distract you from thoughts of drinking and can curb feelings of loneliness or hopelessness that can trigger the urge to drink.
- Exercise: Cycling, swimming, working out, or taking a brisk walk can improve your moods and health by stimulating the production of "feel-good" hormones called endorphins.
- Be persistent: Setbacks are common when adjusting to an alcohol-free lifestyle, but by keeping your eyes on the goal and taking things one day at a time, you'll be more likely to succeed.
What Happens If You Quit Drinking for a Month?
Where to Find Support
Having alcoholic hepatitis can cause extreme stress and fears about the future. It can also trigger feelings of guilt and shame that cause you to isolate yourself, particularly with symptoms like jaundice that you cannot hide.
These are many of the same emotions that cause people to drink excessively—and in secrecy—in the first place. It is for this reason that "going it alone" may not be in your best interest.
While you may not be ready to reach out to family or friends just yet, support symptoms can help you overcome feelings of anxiety and isolation as you embark on treatment.
Two places to start are:
- American Liver Foundation Helpline at 800-GO-LIVER (800-465-4837) for education and local referrals available 9 a.m to 5 p.m. Eastern time Monday through Friday
- Life With Alcohol-Associated Liver Disease, a Facebook support group managed by the American Liver Foundation, for peer support and education
Summary
Alcoholic hepatitis is an advanced stage of alcohol-associated fatty liver disease (AFLD). It is caused by the excessive use of alcohol over months, years, or decades, leading to symptoms like jaundice, fatigue, nausea, and upper abdominal pain.
Mild alcoholic hepatitis may resolve with no lasting injury once drinking is stopped. Severe cases can lead to cirrhosis and liver failure if drinking continues.
The treatment of alcohol hepatitis varies based on the severity of liver injury but invariably involves quitting alcohol. Corticosteroid drugs or a liver transplant may be needed in severe cases.
19 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Im GY. Acute alcoholic hepatitis.Clinics Liver Dis. 2019;23:81-98. doi:10.1016/j.cld.2018.09.005
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance From the American Association for the Study of Liver Diseases.Hepatology. 2020:71(1):306–333. doi:10.1002/hep.30866
Stauber RE, Rautou PE, Steranescu H, Horhat A, Thiele M, Lackner C. Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology. JHEP Rep. 2024;6(5):101055. doi:10.1016/j.jhepr.2024.101055
Dugum MF, McCullough AJ. Acute alcoholic hepatitis, the clinical aspects. Clin Liver Dis. 2016;20(3):499–508. doi:10.1016/j.cld.2016.02.008
Osna NA, Donohue TM Jr, Kharbanda KK.Alcoholic liver disease: pathogenesis and current management.Alcohol Res. 2017;38(2):147-161.
Fargo MV, Grogan SP, Saguil A.Evaluation of jaundice in adults.Am Fam Physician.2017;95(3):164-168.
Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician.2019;100(12):759-770.
Keating M, Lardo O, Hansell M. Alcoholic hepatitis: diagnosis and management. Am Fam Physician.2022;105(4):412-420
Peng Y, Qi X, Guo X. Child–Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95(8):e2877. doi:10.1097/MD.0000000000002877
Morgan TR. Treatment of alcoholic liver disease. Gastroenterol Hepatol (NY). 2017;13(7):425–427.
Nusrat S, Khan MS, Fazili J, Madhoun MF.Cirrhosis and its complications: evidence based treatment.World J Gastroenterol.2014;20(18):5442–5460. doi:10.3748/wjg.v20.i18.5442
Phillips CA, Augustine P, Yerol PK, Rajesh S, Mahadevan P. Severe alcoholic hepatitis: current perspectives. Hepat Med. 2019;11:97–108. doi:10.2147/HMER.S197933
Krishtopaytis E, Kumar P, Almomani A, et al.. Smoking increases the risk for cirrhosis and esophageal varices among patients with non-alcoholic fatty liver disease. Am J Gastroenterol. 2022;117(1OS):e907. doi:10.14309/01.ajg.0000861668.84072.e1
Goldberg D, Zarnegarnia Y. Prediction of long-term survival among patients with cirrhosis using time-varying models. Hepatol Commun. 2023;7(6):e0185. doi:10.1097/HC9.0000000000000185
Kezer CA, Buryska SM, Ahn JC, Kamath PS, Shah VH, Simonetta DA. The mortality index for alcohol-associated hepatitis: a novel prognostic score. Mayo Clinic Proceedings. 2022;97(3):P480-480. doi:10.1016/j.mayocp.2021.10.026
Casadaban LD, Parvinian A, Zivin SP, et al. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort.Ann Hepatol. 2015;14(3):380-388. doi:10.1016/S1665-2681(19)31278-5
McClain CJ, Rios CD, Condon S, Marsano LS. Malnutrition and alcohol-associated hepatitis. Clin Liver Dis. 2021;25(3):557–570. doi:10.1016/j.cld.2021.03.002
Arab JP, Diaz LA, Baeza N, et al. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J Hepatol. 2021;75(5):1026-1033. doi:10.1016/j.jhep.2021.06.019
Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol. 2019;70(2):P328-334. doi:10.1016/j.jhep.2018.11.007
By
Dr. Sifris is an HIV specialist and Medical Director of LifeSense Disease Management. Myhre is a journalist and HIV educator.
See Our Editorial Process
Meet Our Medical Expert Board
Was this page helpful?
Thanks for your feedback!
What is your feedback?